Oxford Biomedica plc is a leading gene and cell therapy company that specializes in developing innovative treatments for serious diseases. Based in Oxford, UK, the company has over 20 years of experience in the field and has established itself as a key player in the biotech industry. With a team of world-class scientists and researchers, Oxford Biomedica is focused on advancing its pipeline of gene and cell therapies, which includes treatments for cancer, neurological disorders, and rare genetic diseases. The company has partnerships with some of the world’s leading pharmaceutical companies and is committed to bringing life-changing therapies to patients in need.
